{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:06:48Z","timestamp":1791212808780,"version":"4.1.0"},"publisher-location":"Totowa, NJ","reference-count":39,"publisher":"Humana Press","isbn-type":[{"value":"9781627032681","type":"print"},{"value":"9781627032698","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T00:00:00Z","timestamp":1351555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T00:00:00Z","timestamp":1351555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-1-62703-269-8_8","type":"book-chapter","created":{"date-parts":[[2013,3,25]],"date-time":"2013-03-25T16:23:30Z","timestamp":1364228610000},"page":"135-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Stereotyped B Cell Receptors in B Cell Leukemias and Lymphomas"],"prefix":"10.1007","author":[{"given":"Nikos","family":"Darzentas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Stamatopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,30]]},"reference":[{"key":"8_CR00081","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0065-230X(01)83004-9","volume":"83","author":"FK Stevenson","year":"2001","unstructured":"Stevenson FK, Sahota SS, Ottensmeier CH, Zhu D, Forconi F, Hamblin TJ (2001) The occurrence and significance of V gene mutations in B cell-derived human malignancy. Adv Cancer Res 83:81\u2013116","journal-title":"Adv Cancer Res"},{"key":"8_CR00082","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1146\/annurev.immunol.21.120601.141018","volume":"21","author":"N Chiorazzi","year":"2003","unstructured":"Chiorazzi N, Ferrarini M (2003) B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol 21:841\u2013894","journal-title":"Annu Rev Immunol"},{"key":"8_CR00083","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1098\/rstb.2000.0751","volume":"356","author":"D Dunn-Walters","year":"2001","unstructured":"Dunn-Walters D, Thiede C, Alpen B, Spencer J (2001) Somatic hypermutation and B-cell lymphoma. Philos Trans R Soc Lond B Biol Sci 356:73\u201382","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"8_CR00084","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1006\/scbi.2001.0423","volume":"12","author":"P Ghia","year":"2002","unstructured":"Ghia P, Granziero L, Chilosi M, Caligaris-Cappio F (2002) Chronic B cell malignancies and bone marrow microenvironment. Semin Cancer Biol 12:149\u2013155","journal-title":"Semin Cancer Biol"},{"key":"8_CR00085","doi-asserted-by":"crossref","unstructured":"O\u2019Brien S, Burger J, Blum KA et al (2011) The Bruton\u2019s Tyrosine Kinase (BTK) inhibitor PCI-32765 induces durable responses in relapsed or refractory (R\/R) chronic lymphocytic leukemia\/small lymphocytic lymphoma (CLL\/SLL): follow-up of a phase Ib\/II study. Blood 118 (Abstract 983)","DOI":"10.1182\/blood.V118.21.983.983"},{"key":"8_CR00086","doi-asserted-by":"crossref","unstructured":"Wang L, Martin P, Blum KA et al (2011) The Bruton\u2019s Tyrosine Kinase inhibitor PCI-32765 is highly active as single-agent therapy in previously-treated mantle cell lymphoma (MCL): preliminary results of a phase II trial. Blood 118 (Abstract 442)","DOI":"10.1182\/blood.V118.21.442.442"},{"key":"8_CR00087","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1182\/blood-2010-07-155663","volume":"117","author":"N Chiorazzi","year":"2011","unstructured":"Chiorazzi N, Ferrarini M (2011) Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood 117:1781\u20131791","journal-title":"Blood"},{"key":"8_CR00088","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/0167-5699(94)90009-4","volume":"15","author":"HW Schroeder Jr","year":"1994","unstructured":"Schroeder HW Jr, Dighiero G (1994) The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today 15:288\u2013294","journal-title":"Immunol Today"},{"key":"8_CR00089","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1172\/JCI3009","volume":"102","author":"F Fais","year":"1998","unstructured":"Fais F, Ghiotto F, Hashimoto S et al (1998) Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 102:1515\u20131525","journal-title":"J Clin Invest"},{"key":"8_CR000810","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1182\/blood-2005-04-1511","volume":"106","author":"K Stamatopoulos","year":"2005","unstructured":"Stamatopoulos K, Belessi C, Hadzidimitriou A et al (2005) Immunoglobulin light chain repertoire in chronic lymphocytic leukemia. Blood 106:3575\u20133583","journal-title":"Blood"},{"key":"8_CR000811","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","volume":"94","author":"RN Damle","year":"1999","unstructured":"Damle RN, Wasil T, Fais F et al (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94:1840\u20131847","journal-title":"Blood"},{"key":"8_CR000812","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","volume":"94","author":"TJ Hamblin","year":"1999","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94:1848\u20131854","journal-title":"Blood"},{"key":"8_CR000813","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.leu.2404457","volume":"21","author":"P Ghia","year":"2007","unstructured":"Ghia P, Stamatopoulos K, Belessi C et al (2007) European Research Initiative on CLL. ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia. Leukemia 21:1\u20133","journal-title":"Leukemia"},{"key":"8_CR000814","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/leu.2011.49","volume":"25","author":"AW Langerak","year":"2011","unstructured":"Langerak AW, Davi F, Ghia P et al (2011) European Research Initiative on CLL (ERIC). Immunoglobulin sequence analysis and prognostication in CLL: guidelines from the ERIC review board for reliable interpretation of problematic cases. Leukemia 25:979\u2013984","journal-title":"Leukemia"},{"key":"8_CR000815","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1084\/jem.181.4.1507","volume":"181","author":"S Hashimoto","year":"1995","unstructured":"Hashimoto S, Dono M, Wakai M et al (1995) Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med 181:1507\u20131517","journal-title":"J Exp Med"},{"key":"8_CR000816","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1182\/blood.V87.9.3869.bloodjournal8793869","volume":"87","author":"DG Efremov","year":"1996","unstructured":"Efremov DG, Ivanovski M, Siljanovski N et al (1996) Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia. Blood 87:3869\u20133876","journal-title":"Blood"},{"key":"8_CR000817","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4049\/jimmunol.158.1.235","volume":"158","author":"TA Johnson","year":"1997","unstructured":"Johnson TA, Rassenti LZ, Kipps TJ (1997) Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol 158:235\u2013246","journal-title":"J Immunol"},{"key":"8_CR000818","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4049\/jimmunol.166.1.95","volume":"166","author":"GF Widhopf 2nd","year":"2001","unstructured":"Widhopf GF 2nd, Kipps TJ (2001) Normal B cells express 51p1-encoded Ig heavy chains that are distinct from those expressed by chronic lymphocytic leukemia B cells. J Immunol 166:95\u2013102","journal-title":"J Immunol"},{"key":"8_CR000819","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1182\/blood-2002-11-3485","volume":"101","author":"G Tobin","year":"2003","unstructured":"Tobin G, Thunberg U, Johnson A et al (2003) Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. Blood 101:4952\u20134957","journal-title":"Blood"},{"key":"8_CR000820","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1182\/blood-2004-03-0818","volume":"104","author":"GF Widhopf 2nd","year":"2004","unstructured":"Widhopf GF 2nd, Rassenti LZ, Toy TL, Gribben JG, Wierda WG, Kipps TJ (2004) Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. Blood 104:2499\u20132504","journal-title":"Blood"},{"key":"8_CR000821","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1172\/JCI19399","volume":"113","author":"F Ghiotto","year":"2004","unstructured":"Ghiotto F, Fais F, Valetto A et al (2004) Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest 113:1008\u20131016","journal-title":"J Clin Invest"},{"key":"8_CR000822","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1084\/jem.20040544","volume":"200","author":"BT Messmer","year":"2004","unstructured":"Messmer BT, Albesiano E, Efremov DG et al (2004) Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia. J Exp Med 200:519\u2013525","journal-title":"J Exp Med"},{"key":"8_CR000823","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1182\/blood-2004-01-0132","volume":"104","author":"G Tobin","year":"2004","unstructured":"Tobin G, Thunberg U, Karlsson K et al (2004) Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood 104:2879\u20132885","journal-title":"Blood"},{"key":"8_CR000824","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","volume":"109","author":"K Stamatopoulos","year":"2007","unstructured":"Stamatopoulos K, Belessi C, Moreno C et al (2007) Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 109:259\u2013270","journal-title":"Blood"},{"key":"8_CR000825","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1182\/blood-2007-07-099564","volume":"111","author":"F Murray","year":"2008","unstructured":"Murray F, Darzentas N, Hadzidimitriou A et al (2008) Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. Blood 111:1524\u20131533","journal-title":"Blood"},{"key":"8_CR000826","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/j.1365-2141.2008.07469.x","volume":"144","author":"R Bomben","year":"2009","unstructured":"Bomben R, Dal Bo M, Capello D et al (2009) Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study. Br J Haematol 144:492\u2013506","journal-title":"Br J Haematol"},{"key":"8_CR000827","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/leu.2009.186","volume":"24","author":"N Darzentas","year":"2010","unstructured":"Darzentas N, Hadzidimitriou A, Murray F et al (2010) A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia 24:125\u2013132","journal-title":"Leukemia"},{"key":"8_CR000828","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1182\/blood-2011-03-343434","volume":"118","author":"A Hadzidimitriou","year":"2011","unstructured":"Hadzidimitriou A, Agathangelidis A, Darzentas N et al (2011) Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases. Blood 118:3088\u20133095","journal-title":"Blood"},{"key":"8_CR000829","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.semcancer.2011.09.009","volume":"21","author":"A Agathangelidis","year":"2011","unstructured":"Agathangelidis A, Hadzidimitriou A, Rosenquist R, Stamatopoulos K (2011) Unlocking the secrets of immunoglobulin receptors in mantle cell lymphoma: implications for the origin and selection of the malignant cells. Semin Cancer Biol 21:299\u2013307","journal-title":"Semin Cancer Biol"},{"key":"8_CR000830","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/leu.2012.3","volume":"26","author":"V Bikos","year":"2012","unstructured":"Bikos V, Darzentas N, Hadzidimitriou A et al (2012) Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications. Leukemia. 26:1638\u20131646]","journal-title":"Leukemia."},{"key":"8_CR000831","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3324\/haematol.2010.025437","volume":"95","author":"S Zibellini","year":"2010","unstructured":"Zibellini S, Capello D, Forconi F et al (2010) Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. Haematologica 95:1792\u20131796","journal-title":"Haematologica"},{"key":"8_CR000832","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1074-7613(00)00006-6","volume":"13","author":"JL Xu","year":"2000","unstructured":"Xu JL, Davis MM (2000) Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 13:37\u201345","journal-title":"Immunity"},{"key":"8_CR000833","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/jmr.679","volume":"17","author":"Y Barrios","year":"2004","unstructured":"Barrios Y, Jirholt P, Ohlin M (2004) Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor. J Mol Recognit 17:332\u2013338","journal-title":"J Mol Recognit"},{"key":"8_CR000834","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/prot.340170108","volume":"17","author":"S Henikoff","year":"1993","unstructured":"Henikoff S, Henikoff JG (1993) Performance evaluation of amino acid substitution matrices. Proteins 17:49\u201361","journal-title":"Proteins"},{"key":"8_CR000835","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3324\/haematol.2011.044792","volume":"96","author":"E Arvaniti","year":"2011","unstructured":"Arvaniti E, Ntoufa S, Papakonstantinou N et al (2011) Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenetic significance in specific subsets of patients. Haematologica 96:1644\u20131652","journal-title":"Haematologica"},{"key":"8_CR000836","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/j.1460-2075.1992.tb05092.x","volume":"11","author":"PM Kirkham","year":"1992","unstructured":"Kirkham PM, Mortari F, Newton JA, Schroeder HW Jr (1992) Immunoglobulin VH clan and family identity predicts variable domain structure and may influence antigen binding. EMBO J 11:603\u2013609","journal-title":"EMBO J"},{"key":"8_CR000837","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/bioinformatics\/14.1.55","volume":"14","author":"I Rigoutsos","year":"1998","unstructured":"Rigoutsos I, Floratos A (1998) Combinatorial pattern discovery in biological sequences: the TEIRESIAS algorithm. Bioinformatics 14:55\u201367","journal-title":"Bioinformatics"},{"key":"8_CR000838","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/jmr.647","volume":"17","author":"C Pommie","year":"2004","unstructured":"Pommie C, Levadoux S, Sabatier R, Lefranc G, Lefranc MP (2004) IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties. J Mol Recognit 17:17\u201332","journal-title":"J Mol Recognit"},{"key":"8_CR000839","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1182\/blood-2011-11-393694","volume":"119","author":"A Agathangelidis","year":"2012","unstructured":"Agathangelidis A, Darzentas N, Hadzidimitriou A et al (2012) Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. Blood 119:4467\u20134475","journal-title":"Blood"}],"container-title":["Methods in Molecular Biology","Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-62703-269-8_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:57:30Z","timestamp":1674521850000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-62703-269-8_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,30]]},"ISBN":["9781627032681","9781627032698"],"references-count":39,"URL":"https:\/\/doi.org\/10.1007\/978-1-62703-269-8_8","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,30]]},"assertion":[{"value":"30 October 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}